Vaishali Pharma Announces Audited Financial Results for the Year Ended March 31, 2026
Vaishali Pharma Limited released its audited financial results for the Quarter and Financial Year ended March 31, 2026, following the approval by the Board of Directors in a meeting held on May 30, 2026. The reported figures provide an overview of the company’s financial performance and position across multiple statements, including standalone and consolidated results.Financial Highlights (Lakhs)
For the year ended March 31, 2026, the company reported strong operational income, though the consolidated statements reflected a different net profit compared to the standalone results.The total income, encompassing revenue from operations and other income, reached 11,260.76 Lakh for the year ended March 31, 2026. Total expenses were recorded at 10,722.07 Lakh.
The consolidated statement showed a Profit/Loss for the year of 13.31 Lakh.
Key Financial Statements Review
The audited financial results for the period are presented below, covering the Standalone Profit and Loss Statement, Consolidated Balance Sheet, and Consolidated Cash Flow Statement.Consolidated Profit and Loss Statement Summary (Year Ended March 31, 2026)
| Particulars | Year Ended Mar 31, 2026 (Audited) | Year Ended Mar 31, 2025 (Audited) |
|---|---|---|
| Revenue from operations | 10,877.23 | 9,902.56 |
| Other income | 383.53 | 320.54 |
| Total Income | 11,260.76 | 10,223.10 |
| Total expenses | 10,722.07 | 10,100.52 |
| Profit before tax | 538.69 | 122.58 |
| Profit/ (Loss) for the year | 13.31 | 81.74 |
| Basic Earnings per share | 0.32 | 0.06 |
Consolidated Statement of Assets and Liabilities (As of March 31, 2026)
| Particulars | As at Mar 31, 2026 (Audited) |
|---|---|
| TOTAL NON-CURRENT ASSETS | 1,042.59 |
| Property, Plant and Equipment | 89.89 |
| Intangible assets under development | 24.91 |
| Total current assets | 11,296.30 |
| Total Assets | 12,338.89 |
| Total Equity attributable to owners of the Company | 6,911.53 |
| Total current liabilities | 4,829.86 |
| Total Equity and Liabilities | 12,338.89 |
Consolidated Cash Flow Statement Summary (Lakhs)
| Activity | Year Ended Mar 31, 2026 (Audited) | Year Ended Mar 31, 2025 (Audited) |
|---|---|---|
| Net cash generated from operating activities (A) | 30.57 | -1,803.83 |
| Net cash generated from investing activities (B) | -533.01 | -19.72 |
| Net cash used in financing activities (C) | 461.15 | 1,850.02 |
| Net increase/ (decrease) in cash and cash equivalents (A+B+C) | -41.28 | 26.47 |
Balance Sheet and Cash Position
The audited standalone statement of assets and liabilities as of March 31, 2026, reported total assets of 12,325.89 Lakh, matching the total equity and liabilities recorded for the year.The company’s current assets stood at 11,296.30 Lakh, largely driven by Trade Receivables of 5,077.26 Lakh, alongside Cash and Cash Equivalents of 110.86 Lakh. In terms of liabilities, total current liabilities were 4,829.86 Lakh.
VAISHALI Stock Price Movement
On Friday, Vaishali Pharma Limited shares slipped by 1.12% to close at ₹7.05. The stock traded on a volume of 152,899 shares, finding support near its day low of ₹6.96.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.